- Anticoagulants, essential for preventing and treating blood clots, are increasingly critical components of modern medical protocols across South Africa, especially in cardiovascular care and post-surgical treatment settings due to their efficacy in reducing thromboembolic risks
- The escalating demand for anticoagulants is primarily fueled by the rising prevalence of cardiovascular diseases, aging population, increasing number of orthopedic and other surgical procedures, and a growing awareness about preventive healthcare
- The oral segment dominated the anticoagulant market with 63.1% share in 2024, driven by the rising adoption of NOACs and improved patient compliance
